Trials / Withdrawn
WithdrawnNCT01422707
Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess
Effect of Short Term Adrenal Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess (CBS003)
- Status
- Withdrawn
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Virginia · Academic / Other
- Sex
- Female
- Age
- 7 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
Short term hydrocortisone to test whether improves excess androgen production from adrenal gland and ovaries
Detailed description
This study will test whether short-term suppression of adrenal function can ameliorate androgen (male hormone) overproduction in overweight girls with androgen excess. The investigators hypothesize that one month of oral hydrocortisone administration will improve androgen levels in girls with adrenal androgen overproduction. Specifically, this intervention will improve androgen levels after adrenal stimulation testing with adrenocorticotropin hormone (ACTH).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydrocortisone | 10 mg/m2/per day PO at bedtime (X4 weeks) |
Timeline
- Start date
- 2018-01-19
- Primary completion
- 2018-07-17
- Completion
- 2018-07-17
- First posted
- 2011-08-24
- Last updated
- 2018-07-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT01422707. Inclusion in this directory is not an endorsement.